The costs and benefits of switching a drug from prescription-only to over-the-counter status: a review of methodological issues and current evidence.

@article{Andersson1992TheCA,
  title={The costs and benefits of switching a drug from prescription-only to over-the-counter status: a review of methodological issues and current evidence.},
  author={Folke Andersson and Evridiki Hatziandreu},
  journal={PharmacoEconomics},
  year={1992},
  volume={2 5},
  pages={
          388-96
        }
}
In recent years various governments, pharmacy associations, consumer groups and the pharmaceutical industry have suggested that more drugs should be switched from prescription-only (Rx) to over-the-counter (OTC) status. Many rationales have been offered, including lowering healthcare costs, taking advantage of pharmacists' training and knowledge, promoting the concept of prevention and self-care, and increasing sales of pharmaceuticals. The purpose of this article is to examine the current… CONTINUE READING